Effectiveness of a Bundled Intervention Including Adjunctive Corticosteroids on Outcomes of Hospitalized Patients With Community-Acquired Pneumonia

Authors:
  • FGFor The Improving Evidence-Based Treatment Gaps
    For The Improving Evidence-Based Treatment Gaps

Abstract
Lower respiratory tract infections, including community-acquired pneumonia (CAP), represent the third leading cause of lost disability-adjusted life years and the leading infectious cause of mortality worldwide.1 In high-income countries, CAP’s burden concentrates predominantly in the elderly,2-4 driving high and rapidly increasing rates of hospitalization and other health care costs.5-7 Challenges to managing CAP now relate to high rates of multimorbidity, which increases the complexity of care and is independently associated with mortality, longer hospitalization, risks of readmission, and poor functional outcomes.8-10

This publication has 41 references indexed in Scilit: